GlobeNewsWire
16 Nov 2026, 06:30 UTC · 19h ago
Lakefront Initiates New €50 Million Share Repurchase Program Following Completion of Initial Share Repurchase Program
Impact · against what's priced in
Lakefront Biotherapeutics' initiation of a new €50 million buyback program provides a positive signal of capital strength and commitment to shareholder returns. Since this doubles the total capital returned since June, it represents a fresh catalyst for EPS growth and institutional appeal.
- LKFT+0.40
No priced-in read yet





